| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615862 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 5 Pages |
Abstract
CNS-directed high-dose chemotherapy and ASCT provides durable remission for patients with synchronous aggressive lymphoma and should be strongly considered as consolidative therapy for eligible patients with systemic NHL with CNS involvement in first complete remission.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
David Qualls, Andrew Sullivan, Shuli Li, Andrew M. Brunner, Kerry Collier, Ephraim Hochberg, Philippe Armand, Tracy T. Batchelor, Yi-Bin Chen, Zachariah DeFilipp,